A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency

NCT04615273 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

264

Enrollment

INDUSTRY

Sponsor class

Conditions

Growth Hormone Deficiency
Endocrine System Diseases
Hormone Deficiency

Interventions

DRUG: Lonapegsomatropin
OTHER: Placebo
DRUG: Somatropin

Sponsor

Ascendis Pharma Endocrinology Division A/S